Perfil del autor: Millán Jiménez, Antonio
Datos institucionales
Nombre | Millán Jiménez, Antonio |
Departamento | Farmacología, Pediatría y Radiología |
Área de conocimiento | Pediatría |
Categoría profesional | Profesor Contratado Doctor (Plaza Vinc.) |
Correo electrónico | Solicitar |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
Estadísticas
-
Nº publicaciones
7
-
Nº visitas
277
-
Nº descargas
352
Publicaciones |
---|
Capítulo de Libro
![]() Salud y confort en el hábitat
(Aula Magna, McGraw-Hill Interamericana de España., 2024)
|
Artículo
![]() The importance of citizen participation in improving comfort and health in obsolete neighbourhoods affected by energy poverty
(Elsevier, 2024)
This study analyses comfort and health in obsolete neighbourhoods in regions with high rates of energy poverty. The Polígono ... |
Artículo
![]() Association between HLA DNA variants and long-term response to anti-TNF drugs in a Spanish pediatric inflammatory bowel disease cohort
(MDPI, 2023)
The genetic polymorphisms rs2395185 and rs2097432 in HLA genes have been associated with the response to anti-TNF treatment ... |
Capítulo de Libro
![]() Aplicación de la estrategia Aura para la rehabilitación de barriadas obsoletas andaluzas: análisis de las condiciones de habitabilidad, confort y salud en el Polígono de San Pablo (Sevilla)
(Junta de Andalucía, Consejería de Fomento, Articulación del Territorio y Vivienda, 2023)
|
Artículo
![]() Confinement, comfort and health: analysis of the real influence of lockdown on university students during the Covid-19 pandemic
(MDPI, 2021)
The COVID-19 pandemic forced the population worldwide into lockdown. The purpose of this study was to assess the impact ... |
Artículo
![]() ![]() Health and habitability in the solar decathlon university competitions: statistical quantification and real influence on comfort conditions
(MDPI, 2020)
Medicine and architecture are disciplines with the main objectives of satisfying the fundamental needs of human beings: ... |
Artículo
![]() Gene signatures of early response to anti-TNF drugs in pediatric inflammatory bowel disease
(MDPI, 2020)
Around a 20–30% of inflammatory bowel disease (IBD) patients are diagnosed before they are 18 years old. Anti-TNF drugs ... |